I am really pleased with this announcement. There’s not a lot more to say than reading between the lines, Tier 1 are big labs/Pharma & Insurance companies wanting this test on board for USA healthcare to save them billions of dollars on dialysis. We knew this was coming PIQ people. Not going to speculate on who, but Janssen (J&J) collaboration & wanting an option to buy out PromarkerD & predictive testing on both DKD & cardiac disease may well have something to do with voiding this deal. IMO & GLTAH
Ann: PromarkerD US market update, page-4
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
-0.035(5.83%) |
Mkt cap ! $74.01M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 56.5¢ | $169.1K | 294.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13665 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.5¢ | 12245 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |